IE
ASPX

Israel Englander’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Israel Englander’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,160,114
Closed -$116M – 4227
2015
Q1 		$116M Buy
1,160,114
+121,380
+12% +$8.09M 0.22% 77
2014
Q4 		$54.5M Sell
1,038,734
-128,521
-11% -$3.77M 0.12% 201
2014
Q3 		$30M Buy
1,167,255
+505,894
+76% +$10.8M 0.08% 325
2014
Q2 		$14.7M Sell
661,361
-236,796
-26% -$5.18M 0.04% 626
2014
Q1 		$27.6M Buy
+898,157
New +$24.1M 0.08% 319

Israel Englander's ASPX Position: Q2 2015 in Review

Israel Englander sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 1,160,114 shares — an estimated $116M sold.

Israel Englander first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $116M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Israel Englander reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Israel Englander sold 1,160,114 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $116M.
  • Israel Englander first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • Israel Englander's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $116M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.